A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
Conditions: Vivax Malaria Interventions: Drug: Tafenoquine; Drug: Primaquin Sponsors: Menzies School of Health Research; University of Melbourne; Funda ção de Medicina Tropical Dr. Heitor Vieira Dourado; Arba Minch University; Addis Ababa University; Papuan Community Health and Development Foundation, Indonesia; Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Indonesia; Curtin University; Papua New Guinea I nstitute of Medical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
Conditions:   Vivax Malaria;   G6PD Deficiency Intervention:   Combination Product: Revised case management package Sponsors:   Macfarlane Burnet Institute for Medical Research and Public Health Ltd;   Papua New Guinea Institute of Medical Research;   Papua New Guinea National Department of Health;   Menzies School of Health Research;   University of Melbourne;   Medicines for Malaria Venture;   PATH;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2023 Category: Research Source Type: clinical trials

Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
Conditions:   Yaws;   Cutaneous Ulcer Interventions:   Drug: Linezolid Oral Tablet;   Drug: Azithromycin Oral Tablet Sponsors:   Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia;   National Department of Health, Papua New Guinea;   School of Medicine and Health Sciences, University of Papua New Guinea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials